Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Regeneron Pharmaceuticals
(NQ:
REGN
)
992.58
+5.31 (+0.54%)
Streaming Delayed Price
Updated: 11:55 AM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Regeneron Pharmaceuticals
< Previous
1
2
...
30
31
32
33
34
35
36
37
Next >
Stocks That Hit 52-Week Highs On Friday
August 20, 2021
Before 10 a.m. ET on Friday, 52 companies hit new 52-week highs. Highlights: Microsoft (NASDAQ:MSFT) was the biggest company by market cap to set a new 52-week high...
Via
Benzinga
UK Approves Regeneron - Roche's COVID-19 Antibody Cocktail
August 20, 2021
The U.K. drug regulator has approved an antibody cocktail developed by Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Roche Holding AG (OTC: RHHBY) to prevent...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
August 18, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
Understanding Regeneron Pharmaceuticals's Unusual Options Activity
August 06, 2021
On Friday, shares of Regeneron Pharmaceuticals (NASDAQ:REGN
Via
Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck
August 19, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
PreMarket Prep Stock Of The Day: Regeneron
August 18, 2021
Benzinga's PreMarket Prep airs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders and investors tune in to get the major news...
Via
Benzinga
Stocks That Hit 52-Week Highs On Wednesday
August 18, 2021
Before 10 a.m. ET on Wednesday, 77 companies hit new 52-week highs. Areas of Significance: Pfizer (NYSE:PFE) was the largest firm on a market cap basis to set a new...
Via
Benzinga
5 Stocks Insiders Are Selling
August 18, 2021
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to...
Via
Benzinga
JD.com And Tesla Lead The Nasdaq Lower Tuesday
August 17, 2021
U.S. indices were trading lower Tuesday amid macro uncertainty due to COVID-19 concerns. Investors also weighed today's Home Depot (NYSE: HD) earnings and a drop in...
Via
Benzinga
Exposures
COVID-19
Stocks That Hit 52-Week Highs On Tuesday
August 17, 2021
Before 10 a.m. ET on Tuesday, 55 companies set new 52-week highs. Points of Interest: Apple (NASDAQ:AAPL) was the largest company by market cap to set a new 52-week...
Via
Benzinga
Novartis Shares Two Year Beovu Data From Diabetic Macular Edema Studies
August 17, 2021
Novartis AG (NYSE: NVS) has reported data from two Phase 3 trials assessing Beovu (brolucizumab) 6 mg versus Regeneron Pharmaceuticals Inc's (NASDAQ: REGN...
Via
Benzinga
3 Growth Stocks Cathie Wood Is Selling That Are Still Worth Buying
August 17, 2021
Wood might regret trimming her positions in these great growth stocks.
Via
The Motley Fool
Large Cap Biopharma Stocks provide Growth and Value
August 16, 2021
The S&P 500 Healthcare Index was up 0.53% and biotech still lags in healthcare yet Large Cap Biopharma is doing well YTD.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Regeneron's Antibody Cocktail Authorized for Preventing COVID: Why It's Not a Big Deal for the Stock
August 14, 2021
The biotech's EUA expansion for REGEN-COV will probably provide only an incremental sales boost.
Via
The Motley Fool
Exposures
COVID-19
eBay And AMD Lead The QQQ Friday
August 13, 2021
U.S. indices traded flat for much of Friday’s session as concerns over the COVID-19 Delta variant continues to cause market uncertainty. The Invesco QQQ Trust Series 1...
Via
Benzinga
Exposures
COVID-19
Vaccine Stocks Fly On Booster Shot OK, But Their Run Could Be Short-Lived
August 13, 2021
Vaccine stocks popped Friday after the FDA authorized a third dose of their Covid shots from some immunocompromised people.
Via
Investor's Business Daily
Exposures
Product Safety
What Rinvoq's Positive News Means for AbbVie
August 13, 2021
If the drug can overcome JAK inhibitor-class concerns, it could capture share in the growing atopic dermatitis market.
Via
The Motley Fool
Ocular Therapeutix, Regeneron Cull Aflibercept Agreement For Retinal Diseases
August 06, 2021
Ocular Therapeutix Inc (NASDAQ: OCUL) and Regeneron Pharmaceuticals Inc (NASDAQ: REGN) have terminated the option and license agreement collaboration. The...
Via
Benzinga
Regeneron Pharmaceuticals Inc (REGN) Q2 2021 Earnings Call Transcript
August 05, 2021
REGN earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Exicure Shares Interim Cavrotolimod Data From Early-Stage Trial In Solid Tumor Patients
August 05, 2021
Exicure Inc (NASDAQ: XCUR) has reported interim results from Phase 1b/2 trial evaluating cavrotolimod (AST-008) in patients with advanced or metastatic solid...
Via
Benzinga
Delta, Lambda Covid Variants Still Weighing On Market Despite Positive Earnings Reports
August 05, 2021
The market is still in a waiting mode, with a lot hinging on tomorrow’s jobs report. Predictions of a volatile, choppy week in the equity markets did not disappoint on...
Via
Benzinga
Sanofi - Regeneron's Libtayo/Chemo Treatment Improves Overall Survival First-Line Lung Cancer
August 05, 2021
The Phase 3 trial of Sanofi SA (NASDAQ: SNY) and Regeneron Pharmaceuticals Inc's (NASDAQ: REGN) Libtayo in combination with platinum-doublet chemotherapy...
Via
Benzinga
Regeneron Beats Street Estimates Big In Q2 As COVID-19 Antibody Boosts Topline, Cuts FY21 R&D Spend Outlook
August 05, 2021
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) earned $25.80 per share for the second quarter, beating the $17.69 estimate. It clocked revenue of $5.1 billion,...
Via
Benzinga
Exposures
COVID-19
Regeneron Pharmaceuticals: Q2 Earnings Insights
August 05, 2021
Shares of Regeneron Pharmaceuticals (NASDAQ:REGN) moved higher by 0.0% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share...
Via
Benzinga
Regeneron Earnings Obliterate Views; Biotech Giant Tops Buy Point
August 05, 2021
Regeneron earnings and sales boomed far above forecasts. The biotech giant rose above a buy point.
Via
Investor's Business Daily
3 Biotech Stocks That Could Make You Richer in August (and Beyond)
August 05, 2021
All three have blockbuster products already on the market.
Via
The Motley Fool
Market Briefing For Tuesday, Aug. 3
August 03, 2021
We do see Tuesday turnaround as a rebound from Monday's just modest fade. Again our wildcard continues to be Covid; and the 'presumed' dovish Fed as relates to 'tapering'.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
10 Biggest Price Target Changes For Monday
August 02, 2021
Raymond James raised Edwards Lifesciences Corporation (NYSE:
Via
Benzinga
FDA Approves Regeneron - Roche's COVID-19 Antibody Cocktail For Post-Exposure Prophylaxis
August 02, 2021
Following the June update that
Via
Benzinga
Exposures
COVID-19
Product Safety
< Previous
1
2
...
30
31
32
33
34
35
36
37
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.